Fate Therapeutics, Inc. dividends

Sorry, we have no dividends for Fate Therapeutics, Inc. (FATE) at the moment. :(

FATE

Price: $3.70

52 week price:
1.63
8.83

Earnings Per Share: -1.64 USD

P/E Ratio: -3.92

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.6 million

Ebitda: -10.1 million

Market Capitalization: 465.4 million

Links: